Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Comprising 15 amino acids with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, BPC-157 has become one of the most widely referenced research peptides in preclinical literature
GHK-Cu is the copper-bound form of GHK, which is used in research to study peptidecopper interactions and related signaling behavior
ND:YAG, Neodymium-Doped Yttrium Aluminium Garnet
(FDA import alert document placing BPC-157 on detention list.) World Anti-Doping Agency
Risk increases significantly in individuals with copper metabolism disorders (Wilsons Disease)
Glucose Homeostasis and Insulin Secretion The blend provides comprehensive glucose regulation through multiple mechanisms[7]: Glucose-dependent insulin secretion enhanced through both GLP-1R and GIPR activation Glucagon suppression during hyperglycemia via GLP-1R signaling Reduced postprandial glucose excursions through delayed gastric emptying Improved insulin sensitivity resulting from weight reduction and metabolic improvements Research demonstrates that the combination approach achieves HbA1c reductions exceeding 2% in type 2 diabetes models while maintaining favorable hypoglycemia risk profiles
